PAHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Phibro Animal Health Corp (PAHC) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, positive technical indicators, and raised guidance outweigh the lack of recent trading signals and neutral sentiment from insiders and hedge funds.
The technical indicators are bullish. The MACD is positively expanding (0.377), the RSI (66.878) is neutral but leaning towards overbought territory, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 56.555), suggesting potential upside.
Raised FY26 guidance, Q2 beat, notable margin expansion, and strong financial performance with significant YoY growth in revenue (+20.90%), net income (+762.14%), and EPS (+737.50%).
Neutral sentiment from insiders and hedge funds, and a 60% chance of short-term price declines (-2.21% next day, -5.21% next week, -5.29% next month).
In Q2 2026, revenue increased by 20.90% YoY to $373.91M, net income surged 762.14% YoY to $27.46M, EPS grew 737.50% to 0.67, and gross margin improved by 6.66% to 35.7%.
Morgan Stanley raised the price target from $45 to $49 and maintained an Equal Weight rating, citing solid execution in the Animal Health segment and cost management.
